nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycine—GARS—peripheral nervous system—multiple sclerosis	0.0141	0.0302	CbGeAlD
Glycine—SLC6A5—brainstem—multiple sclerosis	0.0128	0.0273	CbGeAlD
Glycine—GARS—nerve—multiple sclerosis	0.011	0.0236	CbGeAlD
Glycine—GRIN2C—nerve—multiple sclerosis	0.0108	0.0232	CbGeAlD
Glycine—Aminolevulinic acid—SLC15A2—multiple sclerosis	0.0107	1	CrCbGaD
Glycine—SLC6A5—spinal cord—multiple sclerosis	0.00794	0.017	CbGeAlD
Glycine—GRIN2A—nerve—multiple sclerosis	0.00748	0.016	CbGeAlD
Glycine—SLC32A1—medulla oblongata—multiple sclerosis	0.00698	0.015	CbGeAlD
Glycine—SLC6A9—medulla oblongata—multiple sclerosis	0.00675	0.0144	CbGeAlD
Glycine—GLRA2—brainstem—multiple sclerosis	0.00671	0.0144	CbGeAlD
Glycine—SLC6A5—nervous system—multiple sclerosis	0.00669	0.0143	CbGeAlD
Glycine—SLC6A5—central nervous system—multiple sclerosis	0.00644	0.0138	CbGeAlD
Glycine—SLC32A1—spinal cord—multiple sclerosis	0.00623	0.0133	CbGeAlD
Glycine—SLC6A9—midbrain—multiple sclerosis	0.00617	0.0132	CbGeAlD
Glycine—SLC6A9—spinal cord—multiple sclerosis	0.00602	0.0129	CbGeAlD
Glycine—GCAT—brainstem—multiple sclerosis	0.00592	0.0127	CbGeAlD
Glycine—GLYATL2—nervous system—multiple sclerosis	0.00569	0.0122	CbGeAlD
Glycine—Blindness transient—Methotrexate—multiple sclerosis	0.00558	0.0512	CcSEcCtD
Glycine—GLYATL2—central nervous system—multiple sclerosis	0.00547	0.0117	CbGeAlD
Glycine—SLC32A1—nervous system—multiple sclerosis	0.00525	0.0112	CbGeAlD
Glycine—SLC6A5—brain—multiple sclerosis	0.00511	0.0109	CbGeAlD
Glycine—GLRA3—nervous system—multiple sclerosis	0.00507	0.0109	CbGeAlD
Glycine—SLC6A9—nervous system—multiple sclerosis	0.00507	0.0109	CbGeAlD
Glycine—SLC32A1—central nervous system—multiple sclerosis	0.00505	0.0108	CbGeAlD
Glycine—SLC32A1—cerebellum—multiple sclerosis	0.00494	0.0106	CbGeAlD
Glycine—GLRA3—central nervous system—multiple sclerosis	0.00488	0.0104	CbGeAlD
Glycine—SLC6A9—central nervous system—multiple sclerosis	0.00488	0.0104	CbGeAlD
Glycine—GARS—brainstem—multiple sclerosis	0.00472	0.0101	CbGeAlD
Glycine—GRIN2C—brainstem—multiple sclerosis	0.00465	0.00995	CbGeAlD
Glycine—GARS—retina—multiple sclerosis	0.00456	0.00976	CbGeAlD
Glycine—GLDC—medulla oblongata—multiple sclerosis	0.00456	0.00976	CbGeAlD
Glycine—GATM—brainstem—multiple sclerosis	0.00448	0.0096	CbGeAlD
Glycine—GLYATL2—brain—multiple sclerosis	0.00435	0.00931	CbGeAlD
Glycine—GLRA1—nervous system—multiple sclerosis	0.00431	0.00923	CbGeAlD
Glycine—PIPOX—medulla oblongata—multiple sclerosis	0.00425	0.00911	CbGeAlD
Glycine—GLDC—midbrain—multiple sclerosis	0.00416	0.00892	CbGeAlD
Glycine—GLRA1—central nervous system—multiple sclerosis	0.00415	0.00888	CbGeAlD
Glycine—GCSH—nervous system—multiple sclerosis	0.00413	0.00885	CbGeAlD
Glycine—GCAT—medulla oblongata—multiple sclerosis	0.00413	0.00884	CbGeAlD
Glycine—GLDC—spinal cord—multiple sclerosis	0.00406	0.0087	CbGeAlD
Glycine—AGXT—cerebellum—multiple sclerosis	0.00406	0.00868	CbGeAlD
Glycine—SLC32A1—brain—multiple sclerosis	0.00401	0.00859	CbGeAlD
Glycine—GCSH—central nervous system—multiple sclerosis	0.00398	0.00852	CbGeAlD
Glycine—SHMT2—retina—multiple sclerosis	0.00397	0.00849	CbGeAlD
Glycine—GCSH—cerebellum—multiple sclerosis	0.00389	0.00833	CbGeAlD
Glycine—PIPOX—midbrain—multiple sclerosis	0.00389	0.00833	CbGeAlD
Glycine—GLRA3—brain—multiple sclerosis	0.00387	0.0083	CbGeAlD
Glycine—SLC6A9—brain—multiple sclerosis	0.00387	0.0083	CbGeAlD
Glycine—PIPOX—spinal cord—multiple sclerosis	0.00379	0.00812	CbGeAlD
Glycine—GCAT—midbrain—multiple sclerosis	0.00377	0.00808	CbGeAlD
Glycine—Electrolyte imbalance—Methylprednisolone—multiple sclerosis	0.00368	0.0338	CcSEcCtD
Glycine—GCAT—spinal cord—multiple sclerosis	0.00368	0.00788	CbGeAlD
Glycine—ALAS1—medulla oblongata—multiple sclerosis	0.00362	0.00775	CbGeAlD
Glycine—GLRA2—nervous system—multiple sclerosis	0.00351	0.00752	CbGeAlD
Glycine—GLDC—nervous system—multiple sclerosis	0.00342	0.00733	CbGeAlD
Glycine—GLRA2—central nervous system—multiple sclerosis	0.00338	0.00724	CbGeAlD
Glycine—Electrolyte imbalance—Dexamethasone—multiple sclerosis	0.00335	0.0308	CcSEcCtD
Glycine—Electrolyte imbalance—Betamethasone—multiple sclerosis	0.00335	0.0308	CcSEcCtD
Glycine—GLRA2—cerebellum—multiple sclerosis	0.00331	0.00708	CbGeAlD
Glycine—ALAS1—midbrain—multiple sclerosis	0.00331	0.00708	CbGeAlD
Glycine—GLDC—central nervous system—multiple sclerosis	0.0033	0.00706	CbGeAlD
Glycine—GARS—medulla oblongata—multiple sclerosis	0.00329	0.00705	CbGeAlD
Glycine—GRIN2C—medulla oblongata—multiple sclerosis	0.00324	0.00694	CbGeAlD
Glycine—ALAS1—spinal cord—multiple sclerosis	0.00323	0.00691	CbGeAlD
Glycine—GLDC—cerebellum—multiple sclerosis	0.00322	0.0069	CbGeAlD
Glycine—GRIN2A—brainstem—multiple sclerosis	0.00321	0.00688	CbGeAlD
Glycine—PIPOX—nervous system—multiple sclerosis	0.0032	0.00684	CbGeAlD
Glycine—SLC36A1—brainstem—multiple sclerosis	0.00319	0.00683	CbGeAlD
Glycine—GCSH—brain—multiple sclerosis	0.00316	0.00676	CbGeAlD
Glycine—GCAT—nervous system—multiple sclerosis	0.0031	0.00664	CbGeAlD
Glycine—PIPOX—central nervous system—multiple sclerosis	0.00308	0.00659	CbGeAlD
Glycine—GARS—midbrain—multiple sclerosis	0.00301	0.00645	CbGeAlD
Glycine—PIPOX—cerebellum—multiple sclerosis	0.00301	0.00644	CbGeAlD
Glycine—GCAT—central nervous system—multiple sclerosis	0.00299	0.00639	CbGeAlD
Glycine—GARS—spinal cord—multiple sclerosis	0.00294	0.00629	CbGeAlD
Glycine—GCAT—cerebellum—multiple sclerosis	0.00292	0.00625	CbGeAlD
Glycine—GATM—midbrain—multiple sclerosis	0.00286	0.00612	CbGeAlD
Glycine—GSS—brainstem—multiple sclerosis	0.00281	0.00602	CbGeAlD
Glycine—GATM—spinal cord—multiple sclerosis	0.00279	0.00597	CbGeAlD
Glycine—GNMT—brain—multiple sclerosis	0.00276	0.00591	CbGeAlD
Glycine—ALAS1—nervous system—multiple sclerosis	0.00272	0.00582	CbGeAlD
Glycine—GSS—retina—multiple sclerosis	0.00271	0.0058	CbGeAlD
Glycine—GLRB—medulla oblongata—multiple sclerosis	0.00269	0.00575	CbGeAlD
Glycine—GLRA2—brain—multiple sclerosis	0.00269	0.00575	CbGeAlD
Glycine—SHMT2—midbrain—multiple sclerosis	0.00262	0.00561	CbGeAlD
Glycine—GLDC—brain—multiple sclerosis	0.00262	0.0056	CbGeAlD
Glycine—ALAS1—central nervous system—multiple sclerosis	0.00262	0.0056	CbGeAlD
Glycine—ALAS1—cerebellum—multiple sclerosis	0.00256	0.00548	CbGeAlD
Glycine—GARS—nervous system—multiple sclerosis	0.00248	0.0053	CbGeAlD
Glycine—GLRB—midbrain—multiple sclerosis	0.00245	0.00526	CbGeAlD
Glycine—PIPOX—brain—multiple sclerosis	0.00244	0.00523	CbGeAlD
Glycine—GRIN2C—nervous system—multiple sclerosis	0.00244	0.00521	CbGeAlD
Glycine—GLRB—spinal cord—multiple sclerosis	0.00239	0.00513	CbGeAlD
Glycine—GARS—central nervous system—multiple sclerosis	0.00238	0.0051	CbGeAlD
Glycine—GCAT—brain—multiple sclerosis	0.00237	0.00507	CbGeAlD
Glycine—GATM—nervous system—multiple sclerosis	0.00235	0.00503	CbGeAlD
Glycine—GRIN2C—central nervous system—multiple sclerosis	0.00234	0.00502	CbGeAlD
Glycine—GARS—cerebellum—multiple sclerosis	0.00233	0.00499	CbGeAlD
Glycine—Back pain—Fingolimod—multiple sclerosis	0.00232	0.0213	CcSEcCtD
Glycine—GRIN2C—cerebellum—multiple sclerosis	0.00229	0.00491	CbGeAlD
Glycine—GATM—central nervous system—multiple sclerosis	0.00226	0.00484	CbGeAlD
Glycine—Vision blurred—Fingolimod—multiple sclerosis	0.00226	0.0208	CcSEcCtD
Glycine—GRIN2A—medulla oblongata—multiple sclerosis	0.00224	0.0048	CbGeAlD
Glycine—GATM—cerebellum—multiple sclerosis	0.00221	0.00473	CbGeAlD
Glycine—SHMT2—nervous system—multiple sclerosis	0.00215	0.00461	CbGeAlD
Glycine—ALAS1—brain—multiple sclerosis	0.00208	0.00445	CbGeAlD
Glycine—SHMT2—central nervous system—multiple sclerosis	0.00207	0.00444	CbGeAlD
Glycine—GRIN2A—midbrain—multiple sclerosis	0.00205	0.00438	CbGeAlD
Glycine—SHMT2—cerebellum—multiple sclerosis	0.00203	0.00434	CbGeAlD
Glycine—GLRB—nervous system—multiple sclerosis	0.00202	0.00432	CbGeAlD
Glycine—GRIN2A—spinal cord—multiple sclerosis	0.002	0.00428	CbGeAlD
Glycine—SHMT1—nervous system—multiple sclerosis	0.00196	0.0042	CbGeAlD
Glycine—GSS—medulla oblongata—multiple sclerosis	0.00196	0.0042	CbGeAlD
Glycine—GLRB—central nervous system—multiple sclerosis	0.00194	0.00416	CbGeAlD
Glycine—GLRB—cerebellum—multiple sclerosis	0.0019	0.00407	CbGeAlD
Glycine—GARS—brain—multiple sclerosis	0.00189	0.00405	CbGeAlD
Glycine—SHMT1—central nervous system—multiple sclerosis	0.00189	0.00404	CbGeAlD
Glycine—GRIN2C—brain—multiple sclerosis	0.00186	0.00399	CbGeAlD
Glycine—SHMT1—cerebellum—multiple sclerosis	0.00184	0.00395	CbGeAlD
Glycine—Hypotension—Fingolimod—multiple sclerosis	0.00183	0.0168	CcSEcCtD
Glycine—GATM—brain—multiple sclerosis	0.0018	0.00385	CbGeAlD
Glycine—GSS—midbrain—multiple sclerosis	0.00179	0.00383	CbGeAlD
Glycine—GSS—spinal cord—multiple sclerosis	0.00175	0.00374	CbGeAlD
Glycine—GRIN2A—nervous system—multiple sclerosis	0.00168	0.0036	CbGeAlD
Glycine—SLC36A1—nervous system—multiple sclerosis	0.00167	0.00358	CbGeAlD
Glycine—SHMT2—brain—multiple sclerosis	0.00165	0.00352	CbGeAlD
Glycine—GRIN2A—central nervous system—multiple sclerosis	0.00162	0.00347	CbGeAlD
Glycine—SLC36A1—central nervous system—multiple sclerosis	0.00161	0.00345	CbGeAlD
Glycine—Encephalopathy—Methotrexate—multiple sclerosis	0.00159	0.0146	CcSEcCtD
Glycine—GRIN2A—cerebellum—multiple sclerosis	0.00158	0.00339	CbGeAlD
Glycine—SLC36A1—cerebellum—multiple sclerosis	0.00157	0.00337	CbGeAlD
Glycine—GLRB—brain—multiple sclerosis	0.00154	0.0033	CbGeAlD
Glycine—SHMT1—brain—multiple sclerosis	0.0015	0.00321	CbGeAlD
Glycine—Hyponatraemia—Mitoxantrone—multiple sclerosis	0.00149	0.0137	CcSEcCtD
Glycine—GSS—nervous system—multiple sclerosis	0.00147	0.00315	CbGeAlD
Glycine—Lung disorder—Methotrexate—multiple sclerosis	0.00144	0.0132	CcSEcCtD
Glycine—GSS—central nervous system—multiple sclerosis	0.00142	0.00303	CbGeAlD
Glycine—Thrombophlebitis—Prednisolone—multiple sclerosis	0.00141	0.0129	CcSEcCtD
Glycine—Chills—Cladribine—multiple sclerosis	0.0014	0.0129	CcSEcCtD
Glycine—GSS—cerebellum—multiple sclerosis	0.00139	0.00297	CbGeAlD
Glycine—Dehydration—Mitoxantrone—multiple sclerosis	0.00138	0.0127	CcSEcCtD
Glycine—Diarrhoea—Fingolimod—multiple sclerosis	0.00134	0.0123	CcSEcCtD
Glycine—Back pain—Cladribine—multiple sclerosis	0.00132	0.0121	CcSEcCtD
Glycine—Dizziness—Fingolimod—multiple sclerosis	0.00129	0.0119	CcSEcCtD
Glycine—Thrombophlebitis—Triamcinolone—multiple sclerosis	0.00129	0.0119	CcSEcCtD
Glycine—Thrombophlebitis—Methylprednisolone—multiple sclerosis	0.00129	0.0119	CcSEcCtD
Glycine—GRIN2A—brain—multiple sclerosis	0.00129	0.00275	CbGeAlD
Glycine—Visual disturbance—Prednisolone—multiple sclerosis	0.00128	0.0118	CcSEcCtD
Glycine—SLC36A1—brain—multiple sclerosis	0.00128	0.00274	CbGeAlD
Glycine—Thrombophlebitis—Dexamethasone—multiple sclerosis	0.00117	0.0108	CcSEcCtD
Glycine—Thrombophlebitis—Betamethasone—multiple sclerosis	0.00117	0.0108	CcSEcCtD
Glycine—ALAS1—Budesonide—Methylprednisolone—multiple sclerosis	0.00117	0.0866	CbGdCrCtD
Glycine—ALAS1—Budesonide—Dexamethasone—multiple sclerosis	0.00115	0.0852	CbGdCrCtD
Glycine—ALAS1—Budesonide—Betamethasone—multiple sclerosis	0.00115	0.0852	CbGdCrCtD
Glycine—Chills—Azathioprine—multiple sclerosis	0.00114	0.0105	CcSEcCtD
Glycine—GSS—brain—multiple sclerosis	0.00113	0.00241	CbGeAlD
Glycine—ALAS1—Budesonide—Triamcinolone—multiple sclerosis	0.00112	0.0833	CbGdCrCtD
Glycine—Oedema—Cladribine—multiple sclerosis	0.00111	0.0102	CcSEcCtD
Glycine—Tachycardia—Cladribine—multiple sclerosis	0.00108	0.00994	CcSEcCtD
Glycine—Visual disturbance—Dexamethasone—multiple sclerosis	0.00107	0.00984	CcSEcCtD
Glycine—Visual disturbance—Betamethasone—multiple sclerosis	0.00107	0.00984	CcSEcCtD
Glycine—ALAS1—Budesonide—Prednisone—multiple sclerosis	0.00107	0.079	CbGdCrCtD
Glycine—ALAS1—Budesonide—Prednisolone—multiple sclerosis	0.00104	0.0771	CbGdCrCtD
Glycine—Hypotension—Cladribine—multiple sclerosis	0.00104	0.00952	CcSEcCtD
Glycine—Rhinitis—Mitoxantrone—multiple sclerosis	0.00103	0.00945	CcSEcCtD
Glycine—Thrombophlebitis—Prednisone—multiple sclerosis	0.00102	0.00938	CcSEcCtD
Glycine—SLC16A10—cerebellum—multiple sclerosis	0.00101	0.00217	CbGeAlD
Glycine—Pain—Cladribine—multiple sclerosis	0.000949	0.00871	CcSEcCtD
Glycine—Coma—Methotrexate—multiple sclerosis	0.000931	0.00855	CcSEcCtD
Glycine—Chills—Mitoxantrone—multiple sclerosis	0.000921	0.00846	CcSEcCtD
Glycine—Urticaria—Cladribine—multiple sclerosis	0.000882	0.00809	CcSEcCtD
Glycine—Back pain—Mitoxantrone—multiple sclerosis	0.000864	0.00794	CcSEcCtD
Glycine—Thrombophlebitis—Methotrexate—multiple sclerosis	0.000854	0.00784	CcSEcCtD
Glycine—Hypotension—Azathioprine—multiple sclerosis	0.000843	0.00774	CcSEcCtD
Glycine—Vision blurred—Mitoxantrone—multiple sclerosis	0.000842	0.00773	CcSEcCtD
Glycine—Polyuria—Methotrexate—multiple sclerosis	0.000842	0.00773	CcSEcCtD
Glycine—Hypersensitivity—Cladribine—multiple sclerosis	0.000818	0.00751	CcSEcCtD
Glycine—Visual impairment—Prednisolone—multiple sclerosis	0.000812	0.00745	CcSEcCtD
Glycine—Visual disturbance—Methotrexate—multiple sclerosis	0.00078	0.00716	CcSEcCtD
Glycine—Rhinitis—Triamcinolone—multiple sclerosis	0.000776	0.00713	CcSEcCtD
Glycine—Rhinitis—Methylprednisolone—multiple sclerosis	0.000775	0.00711	CcSEcCtD
Glycine—Convulsion—Mitoxantrone—multiple sclerosis	0.000774	0.00711	CcSEcCtD
Glycine—Diarrhoea—Cladribine—multiple sclerosis	0.000759	0.00697	CcSEcCtD
Glycine—Visual impairment—Methylprednisolone—multiple sclerosis	0.000745	0.00684	CcSEcCtD
Glycine—Dizziness—Cladribine—multiple sclerosis	0.000734	0.00674	CcSEcCtD
Glycine—Oedema—Mitoxantrone—multiple sclerosis	0.000729	0.0067	CcSEcCtD
Glycine—ALAS1—Betamethasone—Methylprednisolone—multiple sclerosis	0.000714	0.053	CbGdCrCtD
Glycine—ALAS1—Dexamethasone—Methylprednisolone—multiple sclerosis	0.000714	0.053	CbGdCrCtD
Glycine—Tachycardia—Mitoxantrone—multiple sclerosis	0.000712	0.00654	CcSEcCtD
Glycine—Vomiting—Cladribine—multiple sclerosis	0.000706	0.00648	CcSEcCtD
Glycine—ALAS1—Betamethasone—Dexamethasone—multiple sclerosis	0.000703	0.0521	CbGdCrCtD
Glycine—ALAS1—Dexamethasone—Betamethasone—multiple sclerosis	0.000703	0.0521	CbGdCrCtD
Glycine—Vision blurred—Prednisolone—multiple sclerosis	0.000691	0.00635	CcSEcCtD
Glycine—ALAS1—Betamethasone—Triamcinolone—multiple sclerosis	0.000687	0.0509	CbGdCrCtD
Glycine—ALAS1—Dexamethasone—Triamcinolone—multiple sclerosis	0.000687	0.0509	CbGdCrCtD
Glycine—Hypotension—Mitoxantrone—multiple sclerosis	0.000682	0.00626	CcSEcCtD
Glycine—Visual impairment—Dexamethasone—multiple sclerosis	0.000677	0.00622	CcSEcCtD
Glycine—Visual impairment—Betamethasone—multiple sclerosis	0.000677	0.00622	CcSEcCtD
Glycine—Hypersensitivity—Azathioprine—multiple sclerosis	0.000665	0.0061	CcSEcCtD
Glycine—Nausea—Cladribine—multiple sclerosis	0.000659	0.00605	CcSEcCtD
Glycine—Vertigo—Prednisolone—multiple sclerosis	0.000659	0.00605	CcSEcCtD
Glycine—Back pain—Triamcinolone—multiple sclerosis	0.000652	0.00599	CcSEcCtD
Glycine—ALAS1—Dexamethasone—Prednisone—multiple sclerosis	0.000652	0.0483	CbGdCrCtD
Glycine—ALAS1—Betamethasone—Prednisone—multiple sclerosis	0.000652	0.0483	CbGdCrCtD
Glycine—ALAS1—Betamethasone—Prednisolone—multiple sclerosis	0.000636	0.0472	CbGdCrCtD
Glycine—ALAS1—Dexamethasone—Prednisolone—multiple sclerosis	0.000636	0.0472	CbGdCrCtD
Glycine—Convulsion—Prednisolone—multiple sclerosis	0.000635	0.00583	CcSEcCtD
Glycine—GPR18—GPCR ligand binding—CNR1—multiple sclerosis	0.000634	0.00158	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—RGS1—multiple sclerosis	0.000631	0.00158	CbGpPWpGaD
Glycine—Pain—Mitoxantrone—multiple sclerosis	0.000624	0.00573	CcSEcCtD
Glycine—GARS—Gene Expression—PABPC1—multiple sclerosis	0.000624	0.00156	CbGpPWpGaD
Glycine—Diarrhoea—Azathioprine—multiple sclerosis	0.000617	0.00567	CcSEcCtD
Glycine—GRIN2A—Alzheimers Disease—FAS—multiple sclerosis	0.000612	0.00153	CbGpPWpGaD
Glycine—GRIN2A—CREB phosphorylation through the activation of Ras—MAPK1—multiple sclerosis	0.000608	0.00152	CbGpPWpGaD
Glycine—Vertigo—Triamcinolone—multiple sclerosis	0.000606	0.00556	CcSEcCtD
Glycine—Vertigo—Methylprednisolone—multiple sclerosis	0.000604	0.00555	CcSEcCtD
Glycine—GRIN2C—Activation of NMDA receptor upon glutamate binding and postsynaptic events—MAPK1—multiple sclerosis	0.000604	0.00151	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000602	0.00151	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—CCR1—multiple sclerosis	0.000602	0.00151	CbGpPWpGaD
Glycine—Oedema—Prednisolone—multiple sclerosis	0.000598	0.00549	CcSEcCtD
Glycine—GPR18—Signaling by GPCR—GPR65—multiple sclerosis	0.000598	0.00149	CbGpPWpGaD
Glycine—Dizziness—Azathioprine—multiple sclerosis	0.000597	0.00548	CcSEcCtD
Glycine—GLRB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000596	0.00149	CbGpPWpGaD
Glycine—GLRA1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000596	0.00149	CbGpPWpGaD
Glycine—Convulsion—Triamcinolone—multiple sclerosis	0.000584	0.00536	CcSEcCtD
Glycine—Tachycardia—Prednisolone—multiple sclerosis	0.000584	0.00536	CcSEcCtD
Glycine—Convulsion—Methylprednisolone—multiple sclerosis	0.000583	0.00535	CcSEcCtD
Glycine—GRIN2C—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000581	0.00145	CbGpPWpGaD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000581	0.00145	CbGpPWpGaD
Glycine—Urticaria—Mitoxantrone—multiple sclerosis	0.000579	0.00532	CcSEcCtD
Glycine—GPR18—Signaling Pathways—LINGO1—multiple sclerosis	0.000578	0.00145	CbGpPWpGaD
Glycine—Vomiting—Azathioprine—multiple sclerosis	0.000574	0.00527	CcSEcCtD
Glycine—AGXT2—Metabolism—SRM—multiple sclerosis	0.000572	0.00143	CbGpPWpGaD
Glycine—GPR18—G alpha (i) signalling events—POMC—multiple sclerosis	0.000571	0.00143	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—CXCL10—multiple sclerosis	0.000571	0.00143	CbGpPWpGaD
Glycine—SHMT1—Validated targets of C-MYC transcriptional activation—MMP9—multiple sclerosis	0.000563	0.00141	CbGpPWpGaD
Glycine—GARS—Gene Expression—RPL5—multiple sclerosis	0.000562	0.00141	CbGpPWpGaD
Glycine—GRIN2A—Hypothetical Network for Drug Addiction—MAPK1—multiple sclerosis	0.000562	0.00141	CbGpPWpGaD
Glycine—GRIN2A—Alzheimers Disease—APOE—multiple sclerosis	0.000561	0.0014	CbGpPWpGaD
Glycine—GLYAT—Metabolism—CYP24A1—multiple sclerosis	0.000557	0.00139	CbGpPWpGaD
Glycine—ALAS2—Metabolism—RRM1—multiple sclerosis	0.000557	0.00139	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—CYP27B1—multiple sclerosis	0.000557	0.00139	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—CYP27B1—multiple sclerosis	0.000557	0.00139	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—CYP24A1—multiple sclerosis	0.000557	0.00139	CbGpPWpGaD
Glycine—GLYAT—Metabolism—CYP27B1—multiple sclerosis	0.000557	0.00139	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—CYP24A1—multiple sclerosis	0.000557	0.00139	CbGpPWpGaD
Glycine—GATM—Metabolism—CYP27B1—multiple sclerosis	0.000557	0.00139	CbGpPWpGaD
Glycine—GATM—Metabolism—CYP24A1—multiple sclerosis	0.000557	0.00139	CbGpPWpGaD
Glycine—Oedema—Triamcinolone—multiple sclerosis	0.00055	0.00505	CcSEcCtD
Glycine—Vertigo—Dexamethasone—multiple sclerosis	0.00055	0.00505	CcSEcCtD
Glycine—Vertigo—Betamethasone—multiple sclerosis	0.00055	0.00505	CcSEcCtD
Glycine—GPR18—Signaling by GPCR—CXCL13—multiple sclerosis	0.000547	0.00137	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—CCR1—multiple sclerosis	0.000547	0.00137	CbGpPWpGaD
Glycine—SLC6A5—NRF2 pathway—TGFB1—multiple sclerosis	0.000541	0.00135	CbGpPWpGaD
Glycine—SLC6A9—NRF2 pathway—TGFB1—multiple sclerosis	0.000541	0.00135	CbGpPWpGaD
Glycine—SLC6A5—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000539	0.00135	CbGpPWpGaD
Glycine—SLC6A9—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000539	0.00135	CbGpPWpGaD
Glycine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000537	0.00493	CcSEcCtD
Glycine—Tachycardia—Triamcinolone—multiple sclerosis	0.000537	0.00493	CcSEcCtD
Glycine—Nausea—Azathioprine—multiple sclerosis	0.000536	0.00492	CcSEcCtD
Glycine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000536	0.00492	CcSEcCtD
Glycine—BAAT—Metabolism—CYP24A1—multiple sclerosis	0.000532	0.00133	CbGpPWpGaD
Glycine—BAAT—Metabolism—CYP27B1—multiple sclerosis	0.000532	0.00133	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000531	0.00133	CbGpPWpGaD
Glycine—Convulsion—Betamethasone—multiple sclerosis	0.00053	0.00487	CcSEcCtD
Glycine—Convulsion—Dexamethasone—multiple sclerosis	0.00053	0.00487	CcSEcCtD
Glycine—GLRB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000527	0.00132	CbGpPWpGaD
Glycine—BAAT—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.00052	0.0013	CbGpPWpGaD
Glycine—Hypotension—Methylprednisolone—multiple sclerosis	0.000513	0.00471	CcSEcCtD
Glycine—Pain—Prednisolone—multiple sclerosis	0.000512	0.0047	CcSEcCtD
Glycine—GLYATL1—Metabolism—GPC5—multiple sclerosis	0.00051	0.00127	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—GPC5—multiple sclerosis	0.00051	0.00127	CbGpPWpGaD
Glycine—GATM—Metabolism—GPC5—multiple sclerosis	0.00051	0.00127	CbGpPWpGaD
Glycine—GLYAT—Metabolism—GPC5—multiple sclerosis	0.00051	0.00127	CbGpPWpGaD
Glycine—Vision blurred—Prednisone—multiple sclerosis	0.000502	0.00461	CcSEcCtD
Glycine—GPR18—Signaling Pathways—TAGAP—multiple sclerosis	0.000501	0.00125	CbGpPWpGaD
Glycine—SHMT1—Folate Metabolism—TNF—multiple sclerosis	0.000501	0.00125	CbGpPWpGaD
Glycine—GRIN2A—Post NMDA receptor activation events—MAPK1—multiple sclerosis	0.0005	0.00125	CbGpPWpGaD
Glycine—Oedema—Betamethasone—multiple sclerosis	0.000499	0.00458	CcSEcCtD
Glycine—Oedema—Dexamethasone—multiple sclerosis	0.000499	0.00458	CcSEcCtD
Glycine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000499	0.00458	CcSEcCtD
Glycine—Visual impairment—Methotrexate—multiple sclerosis	0.000493	0.00453	CcSEcCtD
Glycine—GPR18—GPCR ligand binding—CCL5—multiple sclerosis	0.000491	0.00123	CbGpPWpGaD
Glycine—Tachycardia—Dexamethasone—multiple sclerosis	0.000487	0.00447	CcSEcCtD
Glycine—Tachycardia—Betamethasone—multiple sclerosis	0.000487	0.00447	CcSEcCtD
Glycine—BAAT—Metabolism—GPC5—multiple sclerosis	0.000486	0.00122	CbGpPWpGaD
Glycine—Vertigo—Prednisone—multiple sclerosis	0.000479	0.0044	CcSEcCtD
Glycine—Urticaria—Prednisolone—multiple sclerosis	0.000475	0.00437	CcSEcCtD
Glycine—AGXT—Metabolism—CYP24A1—multiple sclerosis	0.000474	0.00118	CbGpPWpGaD
Glycine—AGXT—Metabolism—CYP27B1—multiple sclerosis	0.000474	0.00118	CbGpPWpGaD
Glycine—GLRA1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000471	0.00118	CbGpPWpGaD
Glycine—Pain—Triamcinolone—multiple sclerosis	0.000471	0.00432	CcSEcCtD
Glycine—GRIN2C—Alzheimers Disease—IL1B—multiple sclerosis	0.000469	0.00117	CbGpPWpGaD
Glycine—Hypotension—Betamethasone—multiple sclerosis	0.000467	0.00428	CcSEcCtD
Glycine—Hypotension—Dexamethasone—multiple sclerosis	0.000467	0.00428	CcSEcCtD
Glycine—SHMT1—Metabolism—SRM—multiple sclerosis	0.000466	0.00117	CbGpPWpGaD
Glycine—SHMT1—Validated targets of C-MYC transcriptional activation—MYC—multiple sclerosis	0.000465	0.00116	CbGpPWpGaD
Glycine—Vomiting—Mitoxantrone—multiple sclerosis	0.000464	0.00426	CcSEcCtD
Glycine—Convulsion—Prednisone—multiple sclerosis	0.000462	0.00424	CcSEcCtD
Glycine—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—MAPK1—multiple sclerosis	0.000461	0.00115	CbGpPWpGaD
Glycine—ALAS1—Metabolism—CYP24A1—multiple sclerosis	0.000459	0.00115	CbGpPWpGaD
Glycine—ALAS1—Metabolism—CYP27B1—multiple sclerosis	0.000459	0.00115	CbGpPWpGaD
Glycine—Chills—Methotrexate—multiple sclerosis	0.000459	0.00421	CcSEcCtD
Glycine—SLC32A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000458	0.00115	CbGpPWpGaD
Glycine—GSS—Metabolism—SRM—multiple sclerosis	0.000454	0.00114	CbGpPWpGaD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000454	0.00114	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000449	0.00112	CbGpPWpGaD
Glycine—GRIN2C—Neuronal System—BCHE—multiple sclerosis	0.000446	0.00111	CbGpPWpGaD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000444	0.00111	CbGpPWpGaD
Glycine—SLC16A10—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000444	0.00111	CbGpPWpGaD
Glycine—GRIN2A—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000444	0.00111	CbGpPWpGaD
Glycine—GARS—Gene Expression—PGR—multiple sclerosis	0.000443	0.00111	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—CCR5—multiple sclerosis	0.000442	0.00111	CbGpPWpGaD
Glycine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000441	0.00405	CcSEcCtD
Glycine—GPR18—Signaling Pathways—S1PR1—multiple sclerosis	0.000438	0.0011	CbGpPWpGaD
Glycine—Urticaria—Triamcinolone—multiple sclerosis	0.000437	0.00401	CcSEcCtD
Glycine—Urticaria—Methylprednisolone—multiple sclerosis	0.000436	0.00401	CcSEcCtD
Glycine—Oedema—Prednisone—multiple sclerosis	0.000435	0.00399	CcSEcCtD
Glycine—AGXT—Metabolism—GPC5—multiple sclerosis	0.000433	0.00108	CbGpPWpGaD
Glycine—Nausea—Mitoxantrone—multiple sclerosis	0.000433	0.00398	CcSEcCtD
Glycine—Back pain—Methotrexate—multiple sclerosis	0.000431	0.00396	CcSEcCtD
Glycine—Pain—Dexamethasone—multiple sclerosis	0.000427	0.00392	CcSEcCtD
Glycine—Pain—Betamethasone—multiple sclerosis	0.000427	0.00392	CcSEcCtD
Glycine—SLC16A10—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000426	0.00107	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—GPC5—multiple sclerosis	0.000426	0.00107	CbGpPWpGaD
Glycine—Tachycardia—Prednisone—multiple sclerosis	0.000424	0.0039	CcSEcCtD
Glycine—GLYATL2—Metabolism—RRM1—multiple sclerosis	0.000422	0.00106	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—RRM1—multiple sclerosis	0.000422	0.00106	CbGpPWpGaD
Glycine—GLYAT—Metabolism—RRM1—multiple sclerosis	0.000422	0.00106	CbGpPWpGaD
Glycine—GATM—Metabolism—RRM1—multiple sclerosis	0.000422	0.00106	CbGpPWpGaD
Glycine—GSS—Biological oxidations—POMC—multiple sclerosis	0.000421	0.00105	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.00042	0.00105	CbGpPWpGaD
Glycine—ALAS1—Metabolism—GPC5—multiple sclerosis	0.00042	0.00105	CbGpPWpGaD
Glycine—Vision blurred—Methotrexate—multiple sclerosis	0.00042	0.00385	CcSEcCtD
Glycine—GLRA1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000417	0.00104	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000413	0.00103	CbGpPWpGaD
Glycine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000405	0.00372	CcSEcCtD
Glycine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000405	0.00371	CcSEcCtD
Glycine—SHMT1—Folate Metabolism—IL6—multiple sclerosis	0.000404	0.00101	CbGpPWpGaD
Glycine—BAAT—Metabolism—RRM1—multiple sclerosis	0.000403	0.00101	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CYP24A1—multiple sclerosis	0.000403	0.00101	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CYP27B1—multiple sclerosis	0.000403	0.00101	CbGpPWpGaD
Glycine—Vertigo—Methotrexate—multiple sclerosis	0.0004	0.00367	CcSEcCtD
Glycine—GPR18—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000399	0.000997	CbGpPWpGaD
Glycine—Urticaria—Dexamethasone—multiple sclerosis	0.000397	0.00364	CcSEcCtD
Glycine—Urticaria—Betamethasone—multiple sclerosis	0.000397	0.00364	CcSEcCtD
Glycine—Dizziness—Prednisolone—multiple sclerosis	0.000396	0.00363	CcSEcCtD
Glycine—GPR18—Signaling by GPCR—CCL3—multiple sclerosis	0.00039	0.000974	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—CCR2—multiple sclerosis	0.000388	0.00097	CbGpPWpGaD
Glycine—Convulsion—Methotrexate—multiple sclerosis	0.000386	0.00354	CcSEcCtD
Glycine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000376	0.00345	CcSEcCtD
Glycine—GPR18—Signaling by GPCR—PTGER4—multiple sclerosis	0.000375	0.000938	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—RGS1—multiple sclerosis	0.000373	0.000932	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000371	0.000929	CbGpPWpGaD
Glycine—AGXT2—Metabolism—GPC5—multiple sclerosis	0.000369	0.000921	CbGpPWpGaD
Glycine—Dizziness—Triamcinolone—multiple sclerosis	0.000364	0.00334	CcSEcCtD
Glycine—Dizziness—Methylprednisolone—multiple sclerosis	0.000363	0.00333	CcSEcCtD
Glycine—GPR18—Signaling by GPCR—CXCR3—multiple sclerosis	0.000362	0.000906	CbGpPWpGaD
Glycine—AGXT—Metabolism—RRM1—multiple sclerosis	0.000359	0.000898	CbGpPWpGaD
Glycine—SHMT1—Disease—GPC5—multiple sclerosis	0.000359	0.000897	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—CNR1—multiple sclerosis	0.000358	0.000895	CbGpPWpGaD
Glycine—GRIN2A—Alzheimers Disease—IL1B—multiple sclerosis	0.000358	0.000895	CbGpPWpGaD
Glycine—GRIN2C—Alzheimers Disease—MAPK1—multiple sclerosis	0.000357	0.000893	CbGpPWpGaD
Glycine—Nausea—Prednisolone—multiple sclerosis	0.000355	0.00326	CcSEcCtD
Glycine—GPR18—Signaling Pathways—GPR65—multiple sclerosis	0.000353	0.000883	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—CCR2—multiple sclerosis	0.000352	0.000881	CbGpPWpGaD
Glycine—SLC32A1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000351	0.000877	CbGpPWpGaD
Glycine—Vomiting—Triamcinolone—multiple sclerosis	0.00035	0.00321	CcSEcCtD
Glycine—Vomiting—Methylprednisolone—multiple sclerosis	0.000349	0.00321	CcSEcCtD
Glycine—ALAS1—Metabolism—RRM1—multiple sclerosis	0.000348	0.00087	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—POMC—multiple sclerosis	0.000346	0.000865	CbGpPWpGaD
Glycine—Urticaria—Prednisone—multiple sclerosis	0.000345	0.00317	CcSEcCtD
Glycine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000342	0.00314	CcSEcCtD
Glycine—Diarrhoea—Betamethasone—multiple sclerosis	0.000342	0.00314	CcSEcCtD
Glycine—GRIN2C—Alzheimers Disease—TNF—multiple sclerosis	0.00034	0.000851	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—BCHE—multiple sclerosis	0.00034	0.00085	CbGpPWpGaD
Glycine—Hypotension—Methotrexate—multiple sclerosis	0.00034	0.00312	CcSEcCtD
Glycine—GPR18—GPCR ligand binding—CCL2—multiple sclerosis	0.000338	0.000846	CbGpPWpGaD
Glycine—Dizziness—Dexamethasone—multiple sclerosis	0.00033	0.00303	CcSEcCtD
Glycine—Dizziness—Betamethasone—multiple sclerosis	0.00033	0.00303	CcSEcCtD
Glycine—SHMT1—Metabolism—CYP24A1—multiple sclerosis	0.000328	0.000821	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CYP27B1—multiple sclerosis	0.000328	0.000821	CbGpPWpGaD
Glycine—Nausea—Triamcinolone—multiple sclerosis	0.000327	0.003	CcSEcCtD
Glycine—Nausea—Methylprednisolone—multiple sclerosis	0.000326	0.00299	CcSEcCtD
Glycine—GPR18—Signaling by GPCR—CNR1—multiple sclerosis	0.000325	0.000813	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000323	0.000808	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CXCL13—multiple sclerosis	0.000323	0.000808	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCR1—multiple sclerosis	0.000323	0.000808	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000322	0.000806	CbGpPWpGaD
Glycine—Hypersensitivity—Prednisone—multiple sclerosis	0.00032	0.00294	CcSEcCtD
Glycine—ALAS2—Metabolism—BCHE—multiple sclerosis	0.00032	0.0008	CbGpPWpGaD
Glycine—GSS—Metabolism—CYP24A1—multiple sclerosis	0.00032	0.0008	CbGpPWpGaD
Glycine—GSS—Metabolism—CYP27B1—multiple sclerosis	0.00032	0.0008	CbGpPWpGaD
Glycine—Vomiting—Dexamethasone—multiple sclerosis	0.000317	0.00292	CcSEcCtD
Glycine—Vomiting—Betamethasone—multiple sclerosis	0.000317	0.00292	CcSEcCtD
Glycine—BAAT—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000313	0.000782	CbGpPWpGaD
Glycine—Pain—Methotrexate—multiple sclerosis	0.000311	0.00285	CcSEcCtD
Glycine—GARS—Gene Expression—VDR—multiple sclerosis	0.000309	0.000774	CbGpPWpGaD
Glycine—AGXT2—Metabolism—RRM1—multiple sclerosis	0.000305	0.000764	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GPC5—multiple sclerosis	0.0003	0.000751	CbGpPWpGaD
Glycine—Diarrhoea—Prednisone—multiple sclerosis	0.000298	0.00273	CcSEcCtD
Glycine—Nausea—Dexamethasone—multiple sclerosis	0.000297	0.00272	CcSEcCtD
Glycine—Nausea—Betamethasone—multiple sclerosis	0.000297	0.00272	CcSEcCtD
Glycine—GPR18—Signaling by GPCR—CXCL10—multiple sclerosis	0.000293	0.000732	CbGpPWpGaD
Glycine—GSS—Metabolism—GPC5—multiple sclerosis	0.000293	0.000732	CbGpPWpGaD
Glycine—Urticaria—Methotrexate—multiple sclerosis	0.000289	0.00265	CcSEcCtD
Glycine—Dizziness—Prednisone—multiple sclerosis	0.000288	0.00264	CcSEcCtD
Glycine—GPR18—GPCR downstream signaling—CCL5—multiple sclerosis	0.000278	0.000694	CbGpPWpGaD
Glycine—Vomiting—Prednisone—multiple sclerosis	0.000276	0.00254	CcSEcCtD
Glycine—SLC6A5—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000274	0.000685	CbGpPWpGaD
Glycine—SLC6A9—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000274	0.000685	CbGpPWpGaD
Glycine—GRIN2A—Alzheimers Disease—MAPK1—multiple sclerosis	0.000273	0.000682	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.00027	0.000675	CbGpPWpGaD
Glycine—SLC32A1—Neuronal System—MAPK1—multiple sclerosis	0.000269	0.000672	CbGpPWpGaD
Glycine—BAAT—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000269	0.000671	CbGpPWpGaD
Glycine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000268	0.00246	CcSEcCtD
Glycine—SLC36A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000263	0.000658	CbGpPWpGaD
Glycine—GRIN2A—Alzheimers Disease—TNF—multiple sclerosis	0.00026	0.000649	CbGpPWpGaD
Glycine—Nausea—Prednisone—multiple sclerosis	0.000258	0.00237	CcSEcCtD
Glycine—SLC16A10—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000255	0.000638	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—CCL5—multiple sclerosis	0.000252	0.00063	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—CCR5—multiple sclerosis	0.00025	0.000625	CbGpPWpGaD
Glycine—SHMT1—Metabolism—RRM1—multiple sclerosis	0.000249	0.000622	CbGpPWpGaD
Glycine—Diarrhoea—Methotrexate—multiple sclerosis	0.000249	0.00228	CcSEcCtD
Glycine—GPR18—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000246	0.000616	CbGpPWpGaD
Glycine—BAAT—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000245	0.000612	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—BCHE—multiple sclerosis	0.000243	0.000607	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—BCHE—multiple sclerosis	0.000243	0.000607	CbGpPWpGaD
Glycine—GATM—Metabolism—BCHE—multiple sclerosis	0.000243	0.000607	CbGpPWpGaD
Glycine—GSS—Metabolism—RRM1—multiple sclerosis	0.000243	0.000607	CbGpPWpGaD
Glycine—GLYAT—Metabolism—BCHE—multiple sclerosis	0.000243	0.000607	CbGpPWpGaD
Glycine—Dizziness—Methotrexate—multiple sclerosis	0.00024	0.00221	CcSEcCtD
Glycine—SHMT1—Disease—RPL5—multiple sclerosis	0.000233	0.000583	CbGpPWpGaD
Glycine—GLRA2—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000233	0.000582	CbGpPWpGaD
Glycine—SLC32A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000233	0.000582	CbGpPWpGaD
Glycine—GLRA3—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000233	0.000582	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000232	0.00058	CbGpPWpGaD
Glycine—BAAT—Metabolism—BCHE—multiple sclerosis	0.000231	0.000579	CbGpPWpGaD
Glycine—Vomiting—Methotrexate—multiple sclerosis	0.000231	0.00212	CcSEcCtD
Glycine—GPR18—Signaling Pathways—CCL3—multiple sclerosis	0.00023	0.000576	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—CCR5—multiple sclerosis	0.000227	0.000568	CbGpPWpGaD
Glycine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	0.000226	0.000565	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000226	0.000564	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—IL2RA—multiple sclerosis	0.000224	0.00056	CbGpPWpGaD
Glycine—SHMT1—Disease—SLC11A1—multiple sclerosis	0.000223	0.000559	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PTGER4—multiple sclerosis	0.000222	0.000554	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PGR—multiple sclerosis	0.000218	0.000546	CbGpPWpGaD
Glycine—Nausea—Methotrexate—multiple sclerosis	0.000216	0.00198	CcSEcCtD
Glycine—GPR18—Signaling Pathways—CXCR3—multiple sclerosis	0.000214	0.000535	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CD28—multiple sclerosis	0.000212	0.00053	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000211	0.000528	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCR2—multiple sclerosis	0.000208	0.00052	CbGpPWpGaD
Glycine—AGXT—Metabolism—BCHE—multiple sclerosis	0.000206	0.000516	CbGpPWpGaD
Glycine—ALAS1—Metabolism—BCHE—multiple sclerosis	0.0002	0.0005	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—POMC—multiple sclerosis	0.000195	0.000489	CbGpPWpGaD
Glycine—ALAS2—Metabolism—APOE—multiple sclerosis	0.000193	0.000481	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CNR1—multiple sclerosis	0.000192	0.00048	CbGpPWpGaD
Glycine—GLRB—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.00019	0.000475	CbGpPWpGaD
Glycine—SHMT1—Disease—CD28—multiple sclerosis	0.000178	0.000446	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—POMC—multiple sclerosis	0.000177	0.000444	CbGpPWpGaD
Glycine—AGXT2—Metabolism—BCHE—multiple sclerosis	0.000175	0.000439	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—CCL2—multiple sclerosis	0.000174	0.000434	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CXCL10—multiple sclerosis	0.000173	0.000432	CbGpPWpGaD
Glycine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	0.000173	0.000432	CbGpPWpGaD
Glycine—GRIN2C—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.00017	0.000425	CbGpPWpGaD
Glycine—ALAS2—Metabolism—POMC—multiple sclerosis	0.000165	0.000414	CbGpPWpGaD
Glycine—SLC16A10—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.00016	0.0004	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—TYK2—multiple sclerosis	0.000158	0.000394	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CD86—multiple sclerosis	0.000151	0.000378	CbGpPWpGaD
Glycine—ALAS2—Metabolism—ALB—multiple sclerosis	0.000151	0.000377	CbGpPWpGaD
Glycine—GLRA1—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.00015	0.000375	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCL5—multiple sclerosis	0.000149	0.000372	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—APOE—multiple sclerosis	0.000146	0.000365	CbGpPWpGaD
Glycine—GATM—Metabolism—APOE—multiple sclerosis	0.000146	0.000365	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—APOE—multiple sclerosis	0.000146	0.000365	CbGpPWpGaD
Glycine—GLYAT—Metabolism—APOE—multiple sclerosis	0.000146	0.000365	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—IL2—multiple sclerosis	0.000144	0.000361	CbGpPWpGaD
Glycine—SHMT1—Metabolism—BCHE—multiple sclerosis	0.000143	0.000357	CbGpPWpGaD
Glycine—GSS—Metabolism—BCHE—multiple sclerosis	0.000139	0.000348	CbGpPWpGaD
Glycine—BAAT—Metabolism—APOE—multiple sclerosis	0.000139	0.000348	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—SPP1—multiple sclerosis	0.000138	0.000345	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCR5—multiple sclerosis	0.000134	0.000335	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000134	0.000334	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL2RA—multiple sclerosis	0.000132	0.000331	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—IL2—multiple sclerosis	0.000131	0.000328	CbGpPWpGaD
Glycine—GRIN2C—Neuronal System—MAPK1—multiple sclerosis	0.00013	0.000326	CbGpPWpGaD
Glycine—GRIN2A—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.00013	0.000324	CbGpPWpGaD
Glycine—SHMT1—Disease—CD86—multiple sclerosis	0.000127	0.000318	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—POMC—multiple sclerosis	0.000125	0.000313	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—POMC—multiple sclerosis	0.000125	0.000313	CbGpPWpGaD
Glycine—GLYAT—Metabolism—POMC—multiple sclerosis	0.000125	0.000313	CbGpPWpGaD
Glycine—GATM—Metabolism—POMC—multiple sclerosis	0.000125	0.000313	CbGpPWpGaD
Glycine—AGXT—Metabolism—APOE—multiple sclerosis	0.000124	0.00031	CbGpPWpGaD
Glycine—GARS—Gene Expression—MYC—multiple sclerosis	0.000123	0.000308	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—APOE—multiple sclerosis	0.000122	0.000305	CbGpPWpGaD
Glycine—ALAS1—Metabolism—APOE—multiple sclerosis	0.00012	0.0003	CbGpPWpGaD
Glycine—BAAT—Metabolism—POMC—multiple sclerosis	0.00012	0.000299	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—ALB—multiple sclerosis	0.000114	0.000286	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—ALB—multiple sclerosis	0.000114	0.000286	CbGpPWpGaD
Glycine—GLYAT—Metabolism—ALB—multiple sclerosis	0.000114	0.000286	CbGpPWpGaD
Glycine—GATM—Metabolism—ALB—multiple sclerosis	0.000114	0.000286	CbGpPWpGaD
Glycine—SHMT1—Disease—CCR5—multiple sclerosis	0.000113	0.000282	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CD80—multiple sclerosis	0.00011	0.000276	CbGpPWpGaD
Glycine—SHMT1—Disease—HLA-A—multiple sclerosis	0.00011	0.000275	CbGpPWpGaD
Glycine—BAAT—Metabolism—ALB—multiple sclerosis	0.000109	0.000273	CbGpPWpGaD
Glycine—AGXT—Metabolism—POMC—multiple sclerosis	0.000107	0.000267	CbGpPWpGaD
Glycine—AGXT2—Metabolism—APOE—multiple sclerosis	0.000106	0.000264	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—POMC—multiple sclerosis	0.000105	0.000262	CbGpPWpGaD
Glycine—ALAS1—Metabolism—POMC—multiple sclerosis	0.000103	0.000258	CbGpPWpGaD
Glycine—SHMT1—Disease—APOE—multiple sclerosis	0.000103	0.000257	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCL2—multiple sclerosis	0.000103	0.000256	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—MAPK1—multiple sclerosis	0.0001	0.000251	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—MAPK1—multiple sclerosis	9.94e-05	0.000249	CbGpPWpGaD
Glycine—AGXT—Metabolism—ALB—multiple sclerosis	9.72e-05	0.000243	CbGpPWpGaD
Glycine—ALAS1—Metabolism—ALB—multiple sclerosis	9.41e-05	0.000235	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TYK2—multiple sclerosis	9.31e-05	0.000233	CbGpPWpGaD
Glycine—SHMT1—Disease—CD80—multiple sclerosis	9.29e-05	0.000232	CbGpPWpGaD
Glycine—AGXT2—Metabolism—POMC—multiple sclerosis	9.06e-05	0.000227	CbGpPWpGaD
Glycine—SHMT1—Metabolism—APOE—multiple sclerosis	8.6e-05	0.000215	CbGpPWpGaD
Glycine—GSS—Metabolism—APOE—multiple sclerosis	8.38e-05	0.00021	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ALB—multiple sclerosis	8.26e-05	0.000207	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.13e-05	0.000203	CbGpPWpGaD
Glycine—SHMT1—Disease—TYK2—multiple sclerosis	7.84e-05	0.000196	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL2—multiple sclerosis	7.75e-05	0.000194	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—IL6—multiple sclerosis	7.71e-05	0.000193	CbGpPWpGaD
Glycine—SHMT1—Metabolism—POMC—multiple sclerosis	7.39e-05	0.000185	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MMP9—multiple sclerosis	7.33e-05	0.000183	CbGpPWpGaD
Glycine—GSS—Metabolism—POMC—multiple sclerosis	7.2e-05	0.00018	CbGpPWpGaD
Glycine—SHMT1—Disease—CD4—multiple sclerosis	7.09e-05	0.000177	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ALB—multiple sclerosis	6.74e-05	0.000168	CbGpPWpGaD
Glycine—GSS—Metabolism—ALB—multiple sclerosis	6.56e-05	0.000164	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—STAT3—multiple sclerosis	6.52e-05	0.000163	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MYC—multiple sclerosis	6.06e-05	0.000152	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TGFB1—multiple sclerosis	6.05e-05	0.000151	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MAPK1—multiple sclerosis	5.93e-05	0.000148	CbGpPWpGaD
Glycine—SHMT1—Disease—STAT3—multiple sclerosis	5.49e-05	0.000137	CbGpPWpGaD
Glycine—SHMT1—Disease—MYC—multiple sclerosis	5.1e-05	0.000128	CbGpPWpGaD
Glycine—SHMT1—Disease—TGFB1—multiple sclerosis	5.09e-05	0.000127	CbGpPWpGaD
Glycine—SHMT1—Disease—MAPK1—multiple sclerosis	4.99e-05	0.000125	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL6—multiple sclerosis	4.56e-05	0.000114	CbGpPWpGaD
Glycine—SHMT1—Disease—IL6—multiple sclerosis	3.83e-05	9.59e-05	CbGpPWpGaD
